Background/Aims: GLP-1 and ghrelin are common appetite-regulating hormones. Both have multiple functions beyond metabolic regulation. However, the effects of GLP-1 and ghrelin on endothelial biology are not fully understood. Here, we investigate the roles of GLP-1 and ghrelin in microvascular endothelial apoptosis and senescence. Methods: Human microvascular endothelial cells (HMECs) were exposed to high glucose/high lipid (HG/HL) conditions and treated with GLP-1 or ghrelin. Cellular apoptosis, senescence, and mitochondrial function were measured. In addition, the MAPK and Akt signaling pathways were examined. Results: Both GLP-1 and ghrelin treatment decreased the number of TUNEL-positive cells and inhibited caspase-3 and PARP cleavage and mitochondrial dysfunction in HG/HL-exposed HMECs. GLP-1, but not ghrelin decreased the number of β-galactosidase (β-gal)-positive cells. Furthermore, GLP-1 and ghrelin inhibited ERK1/2, JNK1/2, and p38 signaling. GLP-1 suppressed Akt signaling, but ghrelin had no effect. Moreover, JNK1/2 and p38 inhibitors, but not ERK1/2 and Akt inhibitors, decreased the number of TUNEL-positive cells. Additionally, only the Akt inhibitor decreased the number of β-gal-positive cells. Conclusion: These results demonstrate that GLP-1 and ghrelin inhibit mitochondrial dysfunction under HG/HL conditions, and suppress endothelial apoptosis via inhibiting JNK1/2 and p38 signaling; moreover, GLP-1 alleviates endothelial senescence via inactivating Akt signaling.
Introduction
Glucagon-like peptide-1 (GLP-1) is an incretin or a neuropeptide derived from the transcription product of the proglucagon gene. It is mainly secreted by the intestinal L cells passages 4-6 were grown to 90% confluence and were then cultured in ECM (FBS-free) for 24 h. Then, HMECs were randomly selected to receive one of the following treatments: normal glucose/normal lipid culture for 24 h (Control, FBS-free); or HG (33.3 mM D-glucose)/HL (250 μM palmitate) [12] culture for 24 h after GLP-1 (1, 10, 100, or 1000 nM) or ghrelin (1, 10, 100, or 1000 nM) treatment for 30 min. In some experiments, HMECs were pre-treated with the Akt inhibitor MK2206 (10 μM), the p38 inhibitor SB203580 (10 μM), the ERK1/2 inhibitor SCH772984 (10 μM), or the JNK1/2 inhibitor SP600125 (20 μM) for 30 min and then subjected to the HG/HL protocol.
Evaluation of apoptosis
Apoptosis was analyzed by an In Situ Cell Death Detection Kit (Roche). Cells were observed by a Nikon microscope (ECLIPSE TE2000-U) with a 20X/0.45 NA air objective lens, and images were captured using a Nikon digital camera DXM1200 F and ACT-1 software (Nikon). The number of TUNEL-positive cells was quantified, and at least 120 cells per dish were counted.
Evaluation of senescence β-galactosidase (β-gal) staining was done with a senescence-associated β-gal Staining Kit (Beyotime, China). Cells were washed three times with PBS and fixed in 4% paraformaldehyde for 15 min at room temperature. Next, the cells were incubated overnight at 37°C in darkness with a working solution containing 0.05 mg/ml X-gal.
Determination of cellular ROS generation
Intracellular ROS levels were kinetically examined by measuring the oxidative conversion of cellpermeable 2', 7'-dichlorofluorescein diacetate (DCFH-DA) to fluorescent dichlorofluorescein (DCF). In brief, cells were seeded at a density of 40, 000 cells/well in 96-well culture dishes. DCFH-DA (10 μM) was added and incubated for 20 min at 37°C. Then, the DCF fluorescence distribution in the cells was analyzed using a SynergyH4 Hybrid Reader (BioTek) with an excitation wavelength of 488 nm and an emission wavelength of 525 nm. Each sample was measured in triplicate and five independent experiments were performed for each group. All the values were normalized to that of the control, which was arbitrarily defined as 1.
Determination of mitochondrial ROS generation
Mitochondrial ROS generation was examined using MitoSOX Red mitochondrial superoxide indicator (Molecular Life Technologies, Netherlands). In brief, cells were seeded in 96-well plates and cultured. Subsequently, cells were incubated with MitoSOX (5 μM) in a KRPH buffer (20 mM HEPES, 5 mM KH 2 PO 4 , 1 mM MgSO 4 , 1 mM CaCl 2 , 136 mM NaCl, and 4.7 mM KCl pH 7.4) at 37°C for 10 min and then washed three times with the KRPH buffer. Fluorescence was measured using a SynergyH4 Hybrid Reader (BioTek) with an excitation wavelength of 510 nm and an emission wavelength of 580 nm. Each sample was measured in triplicate and five independent experiments were performed for each group. All the values were normalized to that of the control, which was arbitrarily defined as 1. 
Western blot analysis
Total protein was extracted from HMECs using Minute TM Total Protein Extraction Kit for animal cultured cells/tissues (Invent Biotechnologies, USA). Protein (40-60 mg) from each sample was separated by SDSP-AGE, transferred onto nitrocellulose membranes, and probed with primary antibodies and then with horseradish peroxidase-conjugated secondary antibodies. The enhanced chemiluminescence signal was quantified using a densitometry program (Gel-pro 4.5 Analyzer, Media Cybernetics). To quantify the protein signal, we subtracted the background and normalized the value to that of β-actin. For the phosphospecific protein, we normalized the signal to the amount of target total protein and β-actin.
Statistical analysis
Each experiment was performed at least in triplicate. Data are presented as the means ± SEM. Oneway ANOVA was used to compare data among groups and then Student's t test (Bonferroni correction) was performed if the result of one-way ANOVA was significant. In each case, significance was defined as P<0.05.
Results

GLP-1 and ghrelin inhibit HG/HL-induced apoptosis in HMECs
We first investigated the biological roles of GLP-1 and ghrelin in HG/HL-induced apoptosis in HMECs. As shown, treating of HMECs with HG/HL for 24 h significantly increased apoptosis as determined by TUNEL assays (Fig. 1A-D) , whereas GLP-1 (1-1000 nM) markedly suppressed the effects of HG/HL on HMECs in a dose-dependent manner ( Fig. 1A and B) . Moreover, ghrelin (1-1000 nM) was similarly effective against HG/HL-induced apoptosis ( Fig. 1C and D) . Additionally, we examined the expression levels of cleaved caspase-3 and PARP by Western blot analysis. As expected, the expression levels of cleaved caspase-3 and PARP were elevated in HG/HL-treated HMECs compared with those in control cells ( Fig. 1E  and F) . However, both GLP-1 (100 nM) and ghrelin (100 nM) significantly attenuated the increased expression levels of cleaved caspase-3 and PARP in HG/HL-treated HMECs ( Fig.  1E and F) .
GLP-1 inhibits HG/HL-induced senescence in HMECs
We further investigated the biological roles of GLP-1 and ghrelin in HG/HL-induced senescence in HMECs using β-gal assays. As shown, treatment of HMECs with HG/HL for 24 h significantly increased the number of β-gal-positive cells compared with normal control cells ( Fig. 2A-D) , whereas GLP-1 (1-1000 nM) markedly suppressed cell senescence in a dose-dependent manner. Unexpectedly, ghrelin (1-1000 nM) showed no effect on HG/HLinduced senescence in HMECs ( Fig. 2C and D) .
GLP-1 and ghrelin suppress HG/HL-induced mitochondrial dysfunction in HMECs
Since oxidative stress and mitochondrial function are closely related in cell apoptosis and senescence, we examined whether GLP-1 and ghrelin play roles in ROS generation and mitochondrial function. HG/HL treatment for 24 h induced a significant increase in ROS generation in the cytoplasm (Fig. 3A and B) and mitochondria ( Fig. 3C and D) . However, the increased ROS levels were largely suppressed by both GLP-1 ( Fig. 3 A and C) and ghrelin ( Fig. 3 B and D) at a concentration of 100 nM. Additionally, cellular OCR ( Fig. 3E and F ) and ATP concentration ( Fig. 3G and H) were significantly suppressed after HG/HL treatment. Nevertheless, both GLP-1 ( Fig. 3E and G) and ghrelin ( Fig. 3F and H) abolished these inhibitory effects at a concentration of 100 nM.
GLP-1 and ghrelin affect the HG/HL-induced activation of Akt and MAPKs in HMECs
Because Akt and MAPK signaling pathways play important roles in cell apoptosis and senescence, we next examined the phosphorylation levels of Akt and MAPKs by Western blot analysis. As shown in Fig. 4A and B, HG/HL treatment for 24 h markedly increased the phosphorylation levels of Akt, ERK1/2, JNK1/2, and p38. Notably, GLP-1 (100 nM) Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry suppressed all of these elevated phosphorylation levels ( Fig. 4A and B). However, ghrelin (100 nM) suppressed phosphorylation levels of ERK1/2, JNK1/2, and p38 without effecting the phosphorylation levels of Akt ( Fig. 4A and B).
GLP-1 and ghrelin inhibit HG/HL-induced apoptosis via inhibiting p38 and JNK1/2
To examine whether GLP-1 and ghrelin-mediated suppression of Akt and MAPK activity is required for the protection against HG/HL-induced apoptosis, Akt and MAPK signaling pathways were blocked using their specific inhibitors. Firstly, HG/HL treatment for 24 h significantly induced apoptosis in HMECs (Fig. 5A-D) . In contrast, these actions were markedly attenuated by the JNK1/2 inhibitor SP600125 (Fig. 5B ) and the p38 inhibitor SB203580 (Fig. 5D ), indicating that p38 and JNK1/2 signaling pathways are mediated in HG/ HL-induced apoptosis. Moreover, apoptosis was suppressed even more significantly when cells were pre-treated with either of the two inhibitors before GLP-1 and ghrelin treatment ( Fig. 5B and D) . Together with the evidence that GLP-1 and ghrelin suppressed HG/HLinduced activation of p38 and JNK1/2 (Fig. 4) , these results suggest that GLP-1 and ghrelin can inhibit HG/HL-induced apoptosis via inhibiting p38 and JNK1/2 signaling pathways. In particular, although GLP-1 and ghrelin suppressed the phosphorylation levels of Akt and ERK1/2, the Akt inhibitor MK2206 (Fig. 5A ) and the ERK1/2 inhibitor SCH772984 (Fig. 5C ) had no effect on HG/HL-induced apoptosis, indicating that the Akt and ERK1/2 signaling pathways do not affect HG/HL-induced apoptosis.
GLP-1 suppresses HG/HL-induced senescence via inhibiting Akt
Because GLP-1 inhibits HG/HL-induced senescence in HMECs, we next examined which signaling pathway was required for its protective role in this process. Akt and MAPK signaling pathways were blocked using their specific inhibitors, and cell senescence was then (Fig. 6A-D) . However, this effect was markedly suppressed by a specific inhibitor for Akt, MK2206 (Fig. 6A) , indicating that the Akt signaling pathway is mediated in HG/ HL-induced senescence. Particularly, pre-treatment with MK2206 before GLP-1 treatment induced a more significant attenuation of senescence (Fig. 6A) . Because GLP-1 suppressed the HG/HL-induced activation of Akt (Fig. 4) , these results suggest that GLP-1 can inhibit HG/ HL-induced senescence via inhibiting Akt signaling pathway. However, inhibitors of MAPK signaling showed no effect on HG/HL-induced senescence in HMECs (Fig. 6B-D) . Therefore, MAPK signaling pathways do not affect HG/HL-induced endothelial senescence. 
Discussion
In the present study, we demonstrated that GLP-1 and ghrelin inhibited HG/HL-induced mitochondrial dysfunction, apoptosis and senescence in HMECs. We showed that GLP-1 and ghrelin suppressed endothelial apoptosis via inhibiting JNK1/2 and p38. Moreover, the GLP-1 and ghrelin are common appetite-regulating hormones, both of which are implicated in body energy balance and metabolic processes. Recently, GLP-1-based therapies have been carried out with promising clinical outcomes for type 2 diabetes mellitus [13] . GLP-1 has a short half-life, so the clinical application of GLP-1 is mediated by inhibiting the activity of the degrading enzyme DPP-IV or by providing GLP-1 analogues or exogenous receptor agonists. Currently, beyond its role in glycemic control, numerous studies have indicated the modulatory role of GLP-1 in endothelial and vascular dysfunction. GLP-1 has been shown to influence eNOS activation and NO production in endothelial cells [13, 14] , and it promotes endothelial cell proliferation and growth via activating eNOS [4] . Moreover, GLP-1 promotes angiogenesis in human umbilical vein endothelial cells through the Akt, PKC, and Src pathways [5] . GLP-1 involvement in inflammatory response has also been investigated. Through a calcium-and AMPK-dependent mechanism, a GLP-1 analogue reduced endothelial cell inflammation in response to TNF-α and LPS stimulation [15] . Importantly, GLP-1 has been shown to have beneficial effect against apoptosis under diverse pathological conditions. It protected endothelial cells against advanced glycation end products (AGEs)-induced apoptosis via suppressing of mitochondrion cytochrome c release [16] . Moreover, the GLP-1 analogue Liraglutide protected against high glucose-induced mitochondrial fragmentation and apoptosis in human endothelial cells [17] . Consistent with these results, our study (Fig. 1A and B) and was accompanied by suppressed cleavage of caspase-3 and PARP ( Fig. 1E and F) . Cell senescence can be induced by physical activation or pathologic injury. Endothelial cell senescence is an important cause of endothelium dysfunction and contributes to vascular ageing. However, the direct effect of GLP-1 on endothelial senescence remains unclear. Our study provided evidence that GLP-1 suppressed endothelial senescence induced by HG/ HL ( Fig. 2A and B) , indicating a novel function of GLP-1 that has potential applications in treating senescence-related diseases.
Ghrelin has been described as a natural ligand for GHSRs. The activation of GHSRs regulates multiple intracellular signaling transmission and exhibits different endocrine and non-endocrine effects. Currently, ghrelin is considered to be a potential agent for treating conditions such as impaired gastrointestinal motility or altered energy balance [18] . Ghrelin can stimulate food intake and can also interacts with other systems beyond the stomach and intestine, such as the reproductive, cardiovascular and immune systems [19] [20] [21] [22] . More recently, emerging evidence has indicated that ghrelin plays modulatory role in endothelial cell biology. Ghrelin attenuated angiogenesis induced by oxLDL in human coronary artery endothelial cells [23] . However, contradictorily, ghrelin stimulated angiogenesis via GHSR1a in rat cardiac microvascular endothelial cells [24] . Ghrelin also interfered with endothelial inflammatory responses. Ghrelin inhibited angiotensin II-induced expression of TNF-α, IL-8, and MCP-1 in human umbilical vein endothelial cells [25] . In addition to these functions, ghrelin has been suggested to be beneficial in attenuating endothelial apoptosis induced by various pathologic stimuli, such as oxidative stress [26] , high glucose [27] , and AGEs [28] . Moreover, in our study, ghrelin significantly suppressed HG/HL-induced apoptosis (Fig. 1C  and D) , as well as the cleavage of caspase-3 and PARP ( Fig. 1E and F) . Most likely, an identical signal was affected by ghrelin, resulting in its anti-apoptotic activity in endothelial cells under different pathologic conditions.
Numerous studies have suggested an important role for ghrelin in organ senescence or ageing. Ghrelin is effective in treating ageing-related changes in food intake, body metabolism, cardiovascular function, adaptive immunity, and neurological activity. Therefore, it has been shown to be a promising agent in alleviating these less than optimal conditions associated with senescence [29] . However, in our study, ghrelin had no effects on modulating senescence in HMECs (Fig. 2C and D) . Perhaps ghrelin can interfere with senescence in a tissue-specific or cell-specific manner. It is unclear whether ghrelin alleviates senescence at the organ level.
Mitochondria, which are the key organelles for cellular ATP production, occupy no less than one-third of the cell volume and supply approximately 90% of the ATP. To date, considerable evidence has indicated that mitochondrial dysfunction, such as altered mitochondrial biogenesis and energy metabolism, and mitochondrial ROS generation are mediated in apoptosis and senescence [30] . However, few studies have reported the effects of GLP-1 and ghrelin on mitochondrial dysfunction. In our study, both GLP-1 and ghrelin inhibited ROS generation in the cytoplasm and mitochondria (Fig. 3A-D) . Furthermore, both hormones alleviated mitochondrial metabolism impairments, including cellular OCR and ATP concentration (Fig. 3E-H) . These results indicated that both GLP-1 and ghrelin can suppress HG/HL-induced mitochondrial dysfunction in endothelial cells.
The Akt and MAPK signaling pathways are implicated in numerous biological processes such as inflammation, proliferation, and apoptosis. Considerable evidence has indicated that the JNK1/2 and p38 MAPK signaling pathways trigger endothelial cell apoptosis signals [30, 31] . Recently, several studies have investigated the underlying mechanisms involved in the protective role of GLP-1 against apoptosis. Inoue et al. reported that GLP-1 analogue Liraglutide had beneficial effects on apoptosis via activating the AMPK-Sirt1 pathway in streptozotocin-induced diabetic rats [32] . Moreover, liraglutide inhibited high glucoseinduced apoptosis in vascular smooth muscle cells by suppressing the ERK1/2 and PI3K/ Akt signaling pathways. In our study, the HG/HL-induced activation of ERK1/2 and Akt was significantly suppressed by GLP-1 (Fig. 4) . However, the inhibitors for ERK1/2 and Akt had no effects on apoptosis in HMECs (Fig. 5A and C [33, 34] . We speculate that anti-apoptotic actions of GLP-1 may be tissue-specific. A study has reported that the p38 MAPK pathway is implicated in GLP-1-induced inhibition of apoptosis in human umbilical vein endothelial cells [35] . In our study, we showed evidence that the HG/HL-induced activation of p38 and JNK1/2 was significantly suppressed by GLP-1 (Fig. 4) . Furthermore, the suppression of p38 and JNK1/2 by their inhibitors significantly abolished apoptosis in HMECs ( Fig. 5B and D) . These results indicate that the p38 and JNK1/2 signaling pathways are required for HG/HL-induced endothelial apoptosis and that the protective roles of GLP-1 against apoptosis occur via inhibiting p38 and JNK1/2 signaling. There is controversy about the role of Akt signaling in cell senescence. Numerous studies demonstrated the pro-senescence activity of the Akt signaling pathway [36] [37] [38] . However, the anti-senescence activity of the Akt signaling pathway has also been proposed in several types of tissues and cells, such as multipotent mesenchymal stem cells [39] . In our study, GLP-1 suppressed HG/HL-induced Akt activation (Fig. 5) and blocking Akt by a specific inhibitor effectively attenuated senescence in HMECs (Fig. 6A) , indicating that the anti-senescence effects of GLP-1 are due to inactivation of the Akt signaling pathway.
Recently, it has been reported that the anti-apoptotic effects of ghrelin in endothelial cells occur via multiple signaling pathways, including the Sirt-1 [26] , mTOR/P70S6K [27] , PI3K/Akt [28, 40] , ERK1/2 [28, 40] , and cAMP/PKA [40] . However, our study showed that despite the inactivation of ERK1/2 signaling by ghrelin (Fig. 4) , inhibiting this pathway by using a specific inhibitor did not lead to changes in apoptosis in HMECs (Fig. 5C ). Regarding the Akt signaling, ghrelin appeared to have no effects (Fig. 4) . Also of note is that the HG/HLinduced activation of JNK1/2 and p38 was markedly inhibited by ghrelin (Fig. 4) . Therefore, these results suggested that ghrelin protects HMECs against HG/HL-induced apoptosis via inactivating JNK1/2 and p38 signaling.
Conclusion
The present study revealed that GLP-1 and ghrelin attenuated mitochondrial dysfunction, endothelial cell apoptosis and senescence induced by HG/HL. The anti-apoptotic effects of GLP-1 and ghrelin are due to their inhibition of the JNK1/2 and p38 signaling pathways. Furthermore, the suppression of Akt signaling is required for the anti-senescence effects Fig. 7) . However, there are limitations to the present study. It is unclear what consequence the suppression of ERK1/2 signaling by GLP-1 and ghrelin produces. In addition, further studies are needed to determine the beneficial effects of GLP-1 and ghrelin on endothelial injury in an in vivo animal model.
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